A detailed history of Broadcrest Asset Management, LLC transactions in Bio Techne Corp stock. As of the latest transaction made, Broadcrest Asset Management, LLC holds 80,000 shares of TECH stock, worth $5.72 Million. This represents 10.06% of its overall portfolio holdings.

Number of Shares
80,000
Previous 300,000 73.33%
Holding current value
$5.72 Million
Previous $23.1 Million 75.67%
% of portfolio
10.06%
Previous 25.12%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$65.98 - $77.09 $14.5 Million - $17 Million
-220,000 Reduced 73.33%
80,000 $5.63 Million
Q4 2023

Feb 09, 2024

BUY
$52.83 - $78.22 $1.32 Million - $1.96 Million
25,000 Added 9.09%
300,000 $23.1 Million
Q3 2023

Nov 09, 2023

SELL
$67.52 - $89.42 $1.69 Million - $2.24 Million
-25,000 Reduced 8.33%
275,000 $18.7 Million
Q2 2023

Aug 16, 2023

BUY
$73.76 - $85.98 $22.1 Million - $25.8 Million
300,000 New
300,000 $24.5 Million

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.8B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Broadcrest Asset Management, LLC Portfolio

Follow Broadcrest Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Broadcrest Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Broadcrest Asset Management, LLC with notifications on news.